Efficacy and safety of brodalumab in the Korean population for the treatment of moderate to severe plaque psoriasis: A randomized, phase III, double‐blind, placebo‐controlled study.

MLA

Seo, Seong Jun, et al. “Efficacy and Safety of Brodalumab in the Korean Population for the Treatment of Moderate to Severe Plaque Psoriasis: A Randomized, Phase III, Double‐blind, Placebo‐controlled Study.” Journal of Dermatology, vol. 48, no. 6, June 2021, pp. 807–17. EBSCOhost, https://doi.org/10.1111/1346-8138.15733.

APA

Seo, S. J., Shin, B. S., Lee, J., & Jeong, H. (2021). Efficacy and safety of brodalumab in the Korean population for the treatment of moderate to severe plaque psoriasis: A randomized, phase III, double‐blind, placebo‐controlled study. Journal of Dermatology, 48(6), 807–817. https://doi.org/10.1111/1346-8138.15733

Chicago

Seo, Seong Jun, Bong Seok Shin, Joo‐Heung Lee, and Haeyoun Jeong. 2021. “Efficacy and Safety of Brodalumab in the Korean Population for the Treatment of Moderate to Severe Plaque Psoriasis: A Randomized, Phase III, Double‐blind, Placebo‐controlled Study.” Journal of Dermatology 48 (6): 807–17. doi:10.1111/1346-8138.15733.